304 related articles for article (PubMed ID: 16167675)
21. Health care and hospital pharmacy in Denmark.
Nedergaard M
Am J Hosp Pharm; 1977 Jun; 34(6):595-600. PubMed ID: 879180
[TBL] [Abstract][Full Text] [Related]
22. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
23. Provider characteristics among staff providing care to sexually transmitted infection self-medicating patients in retail pharmacies in Kibera slum, Nairobi, Kenya.
Kwena Z; Sharma A; Wamae N; Muga C; Bukusi E
Sex Transm Dis; 2008 May; 35(5):480-3. PubMed ID: 18360315
[TBL] [Abstract][Full Text] [Related]
24. A new definition of pharmaceutical quality: assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance.
Short SM; Cogdill RP; D'Amico F; Drennen JK; Anderson CA
J Pharm Sci; 2010 Dec; 99(12):5046-59. PubMed ID: 20574996
[TBL] [Abstract][Full Text] [Related]
25. Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective.
Sreedhara A; Zamiri C; Goswami S; Weiser S; Cram M; Christian TR; Jagannathan B
J Pharm Sci; 2020 Jan; 109(1):22-29. PubMed ID: 31697946
[TBL] [Abstract][Full Text] [Related]
26. Fever case management at private health facilities and private pharmacies on the Kenyan coast: analysis of data from two rounds of client exit interviews and mystery client visits.
Poyer S; Musuva A; Njoki N; Okara R; Cutherell A; Sievers D; Lussiana C; Memusi D; Kiptui R; Ejersa W; Dolan S; Charman N
Malar J; 2018 Mar; 17(1):112. PubMed ID: 29534750
[TBL] [Abstract][Full Text] [Related]
27. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
Zaid AN; Ghosh AA
Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
[TBL] [Abstract][Full Text] [Related]
28. Perceptions and views of regulatory pharmacists on the registration system for generic drugs for human use in Kenya.
Chemwolo AK; Ngondi J; Clark B
East Afr Med J; 2010 Mar; 87(3):120-6. PubMed ID: 23057308
[TBL] [Abstract][Full Text] [Related]
29. Drug quality control work in Daru: observations during 1983-1986.
Kibwage IO; Ogeto JO; Maitai CK; Rutere G; Thuranira J; Ochieng' A
East Afr Med J; 1992 Oct; 69(10):577-80. PubMed ID: 1473513
[TBL] [Abstract][Full Text] [Related]
30. Interchangeability between paracetamol tablets marketed in Palestine. Is there a quality reason for a higher price?
Zaid A; Rinno T; Jaradat N; Jodeh S; Khammash S
East Mediterr Health J; 2013 Jun; 19(6):542-6. PubMed ID: 24975183
[TBL] [Abstract][Full Text] [Related]
31. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacy standards for clinical trials].
Terkola R
Onkologie; 2008; 31 Suppl 2():25-8. PubMed ID: 18487865
[TBL] [Abstract][Full Text] [Related]
33. Assessment of performance of manufacturing procedures in a unit for production of investigational anticancer agents, using a mixed effects analysis.
van der Schoot SC; Nuijen B; Huitema AD; Beijnen JH
Pharm Res; 2007 Mar; 24(3):605-12. PubMed ID: 17245647
[TBL] [Abstract][Full Text] [Related]
34. [The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s].
Sihn KH
Uisahak; 2015 Dec; 24(3):749-81. PubMed ID: 26819439
[TBL] [Abstract][Full Text] [Related]
35. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
[TBL] [Abstract][Full Text] [Related]
36. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities--1995.
Santell JP; Kamalich RF
Am J Health Syst Pharm; 1996 Nov; 53(21):2591-605. PubMed ID: 8913388
[TBL] [Abstract][Full Text] [Related]
37. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
Tauqeer F; Myhr K; Gopinathan U
Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
[TBL] [Abstract][Full Text] [Related]
38. The need for good practices in biomedical technology.
Koech DK
Afr J Health Sci; 1996 Feb; 3(1):1. PubMed ID: 17451285
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
40. Multivariate statistical process control in product quality review assessment - A case study.
Kharbach M; Cherrah Y; Vander Heyden Y; Bouklouze A
Ann Pharm Fr; 2017 Nov; 75(6):446-454. PubMed ID: 28797469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
